Starbucks' new move is aimed at boosting the digital part of its business in China, one of its key markets. Starbucks has collaborated with the venture capital firm Sequoia Capital China to co-invest in development firms in the second largest economy in the world.
This week, as clinical trials on humans were approved in Germany and launched in the UK, the race to produce an effective vaccine against the novel coronavirus has gathered momentum. While about 150 research projects are now being implemented worldwide, the German and British plans are among only five human clinical trials approved worldwide.
The diagnostic authorization — developed by testing giant LabCorp — marks the first time the agency has cleared up a Covid-19 at-home test and ends weeks of back-and-forth between the agency and companies who have tried to produce their own versions of the tests that would allow at-home sampling.
